Published trade mark details for 2519628

This information was published on 2025-02-06T04:24:29 for IP Right Filed Published.

Field	Value
(210)	2519628 (IR 1837720)
(220)	19 Jul 2024
(300)	US, 29 Mar 2024, 98475314
(500)	The mark consists of the word axsome with design elements.
(511) (510)	Class 5 Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, depression, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss. Class 9 Downloadable cloud-based software for the purpose of tracking, managing and storing information related to medications and medication compliance, patient health, wellness and symptoms, and patient diseases and disorders; downloadable software in the nature of a mobile application for the purpose of tracking, managing and storing information related to medications and medication compliance, patient health, wellness and symptoms, and patient diseases and disorders. Class 16 Printed educational materials in the field of migraines. Class 35 Promoting public awareness of migraines. Class 36 Management of pharmacy benefit programs featuring a medical benefit co-pay card (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); financial administration of patient assistance eligibility programs featuring a pharmacy benefit co-pay card; providing financial assistance in the form of prepaid co-pay cards to patients for medical benefits. Class 38 Providing an on-line forum for patients and doctors to communicate and discuss depression and treatments for depression. Class 44 Consulting services in the field of health relating to pharmaceuticals; providing health information relating to pharmaceuticals; providing health information relating to pharmaceuticals via a website; providing medical information relating to pharmaceuticals via a website; providing news and information in the field of medicine relating to pharmaceuticals; providing on-line information, news and commentary in the field of health and wellness relating to pharmaceuticals; providing health information; providing health information via a website; providing medical information via a website; providing medical information in the field of depression and treatments for depression; providing mental health information via a website; providing mental health and wellness information; providing news and information in the field of medicine; providing news and information in the field of mental health about depression and treatments for depression; providing on-line information, news and commentary in the field of health and wellness relating to depression and treatments for depression; providing information in the field of migraines (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing information in the field of migraines via a website (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).
(540)
(550)	Figurative
(730)	Axsome Therapeutics, Inc.

 

Find out more about publications on the About page.